Six pharma companies reported to be under investigation for opioid shipments

US prosecutors have handed subpoenas to six pharmaceutical companies and distributors for their role in the opioid crisis, as reported.

Six pharmaceutical companies are under investigation from the US government as they potentially imported large quantities of opioids which contributed to the crisis in the country, reports Reuters.

According to the outlet, regulatory filings say five businesses have received subpoenas from Brooklyn federal prosecutors: Teva Pharmaceutical Industries Ltd, Mallinckrodt Plc, Johnson & Johnson, Amneal Pharmaceuticals Inc and distributor McKesson Corp.

The Wall Street Journal, which was first to report the investigation, also listed AmerisourceBergen Corp as having received a subpoena.

The report claims that several companies have admitted to receiving grand jury subpoenas, suggesting they are part of a criminal investigation.

Teva is reported to be confident in its supply chain, with its medicine imports delivered according to regulations.